Apple Inc

While the COVID-19 shock is severe in the near term, we think it will be temporary.

We think stocks will eventually recover from this downturn, and investors shouldn't wait on the sidelines until they do.

Broad diversification and low fees make indexing a good bet in this competitive arena.

We recap the week on Morningstar.com and note the most popular stocks, funds, and exchange-traded funds.

Managers continue to buy wide-moat stocks.

Discretion can be the better part of valor.

Yes, sort of, just not the sort of momentum strategy many may think.

Several funds see value in the technology, healthcare, and energy sectors.

We still think it is likely any near-term shortfall will be made up in subsequent quarters.

Vanguard Total World Stock Index offers investors the entire global market in one low-cost package.

Diversification is a powerful tool to control risk.

Wait for a pullback in the sector, which currently has one of its highest price/fair value ratios since 2007.

We’re in the thick of earnings season--and we’ve bumped up our fair value estimates on several popular stocks.

We are raising our fair value estimate for the narrow-moat firm as we incorporate superior near-term prospects.

Reports are also due for Visa, Exxon, Verizon, and many more.

Given their ties with promising technologies, these companies stand to benefit in the 2020s.

As stocks soared, so did the equity-heavy Aggressive Mutual Fund and ETF portfolios.

A very good year for the market.

We think these companies are poised to experience meaningful economic benefits in the future.

Here are the most-viewed securities on Morningstar.com this year.